Mentions
Extended reach
Total likes
Video views
AI synopsis
Overall, discussions demonstrate enthusiasm and appreciation for the research, with posts referencing treatment effectiveness rankings like '0.5 mg/d of oral dutasteride highest efficacy' and phrases such as 'contribute to the comparative effectiveness literature,' which indicate a keen interest in applying these findings. The tone conveys a blend of curiosity and validation of the study's significance in guiding alopecia treatment strategies.
Most discussions recognize the study's findings as credible and useful for treatment decisions, indicating general agreement with the publication's conclusions.
Posts show high interest, citing the relevance of the meta-analysis results and treatment rankings, with mentions of specific medications like dutasteride and minoxidil.
Some posts reference the methodology and implications, such as comparing efficacy and discussing treatment options, reflecting moderate to deep engagement.
While the discussions highlight the importance of the research for clinical choices, the overall perceived impact is moderate, influencing practices but not revolutionizing the field.
Monotherapy with minoxidil, dutasteride and finasteride is used to manage androgenetic alopecia (AGA). The findings of this meta-analysis contribute to the comparative effectiveness literature for AGA therapies wrt the compared interventions. https://t.co/JoDPUkd24t
Monotherapy with minoxidil, dutasteride, and finasteride is used to manage androgenetic alopecia (AGA). The findings of this meta-analysis contribute to the comparative effectiveness literature for AGA therapies wrt the compared interventions. https://t.co/zxTN4muiFq
・男性のAGA患者（平均年齢22.8〜41.8歳） ▶ミノキシジル、デュタステリド、フィナステリド（各種用量・投与経路） ▶24週・48週後の総毛髪数・終毛髪数の変化 → 最も効果が高いのはデュタステリド0.5mg/日 https://t.co/Y26lViZgfe
Cool 2022 meta-analysis comparing the most common pharmacologic treatments for male pattern baldness. 0.5mg dutasteride comes out on top. https://t.co/4z084HXtGN
効果についての論文はこちらです。 デュタステリド0.5mg、フィナステリド5mg、ミノキシジル(外用)の順に有効性が高い可能性があるとのことです。 https://t.co/YB7yUN2c61
Results indicate 0.5 mg/d of oral dutasteride highest probability of being the most efficacious followed by 5 mg/d of oral finasteride, 5 mg/d of oral minoxidil, 1 mg/d of oral finasteride, 5% topical minoxidil, 2% topical minoxidil, and 0.25 mg minoxidil https://t.co/cE9rSAptcp
This video reviews a meta-analysis comparing the efficacy of minoxidil, finasteride, and dutasteride for male hair loss treatment, highlighting the most effective options based on recent research.
This video explores why topical minoxidil is more effective than oral minoxidil for stopping hair loss, highlighting its safety and efficacy in treating androgenetic alopecia, based on recent scientific research.
Recent studies demonstrate HMI-115's potential as a novel treatment for androgenetic alopecia, highlighting positive outcomes from phase I trials and comparing its efficacy with existing therapies like minoxidil and…
This video discusses the relative efficacy of Minoxidil and 5-α reductase inhibitors in treating male androgenetic alopecia, based on a network meta-analysis. It highlights key findings from recent research published in…
Oral Finasteride is FDA-approved for androgenic alopecia. Dutasteride also treats the same symptoms, with some claiming it to be superior. This video examines scientific evidence supporting these claims and discusses…
Finasteride, Dutasteride, and Minoxidil are evaluated for treating androgenetic alopecia. The study shows Dutasteride 0.5 mg daily results in the greatest increase in hair count after 6 months, outperforming Finasteride…
@BerbarianWizard We have?
・男性のAGA患者（平均年齢22.8〜41.8歳） ▶ミノキシジル、デュタステリド、フィナステリド（各種用量・投与経路） ▶24週・48週後の総毛髪数・終毛髪数の変化 → 最も効果が高いのはデュタステリド0.5mg/日 https://t.co/Y26lViZgfe
Cool 2022 meta-analysis comparing the most common pharmacologic treatments for male pattern baldness. 0.5mg dutasteride comes out on top. https://t.co/4z084HXtGN
Most Viewed from across the JAMA Network From @JAMADerm “Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients A Network Meta-analysis” @UofT https://t.co/4oNzbSC195 https://t.co/fmnku8Fe0v
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis | Dermatology | JAMA Dermatology | JAMA Network https://t.co/fFpYT6srKT
効果についての論文はこちらです。 デュタステリド0.5mg、フィナステリド5mg、ミノキシジル(外用)の順に有効性が高い可能性があるとのことです。 https://t.co/YB7yUN2c61
RT @drdaviperezmeza: Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A…
RT @drdaviperezmeza: Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A…
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis | Dermatology | JAMA Dermatology | JAMA Network https://t.co/fFpYT6srKT
@Wangjackson9427 @JoseOrtiz_C @EnMexicoMagico https://t.co/U2nuWodSfk
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients… https://t.co/J8WJxIghee 読んでみたら❣️
HAIR LOSS TREATMENT RANKED: MINOXIDIL, FINASTERIDE, DUTASTERIDE
Results indicate 0.5 mg/d of oral dutasteride highest probability of being the most efficacious followed by 5 mg/d of oral finasteride, 5 mg/d of oral minoxidil, 1 mg/d of oral finasteride, 5% topical minoxidil, 2% topical minoxidil, and 0.25 mg minoxidil https://t.co/cE9rSAptcp
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment https://t.co/42jgRmppRh via @JAMADerm part of @JAMANetwork
Monotherapy with minoxidil, dutasteride, and finasteride is used to manage androgenetic alopecia (AGA). The findings of this meta-analysis contribute to the comparative effectiveness literature for AGA therapies wrt the compared interventions. https://t.co/zxTN4muiFq
ハゲ治療のネットワークメタ解析① (JAMA dermatology誌, 2022) 現時点で世界一信頼できるデータ 24週後の毛髪量ランキング デュタステリド0.5mg＞フィナステリド5mg ＞ミノキシジル液5%＞デュタステリド0.1mg ＞フィナステリド1mg＞ミノキシジル2％ ＞ミノキシジル5mg https://t.co/JRNXBlRUyt
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis, from @JAMADerm, free online during #AAD2022. Includes editorial https://t.co/hGcoLinghn https://t.co/yQ2uww959N
LDOM is a great option vs topical Minoxidil for scalp irritation/allergy cases, but in my opinion, is COMPLIANCE of the topical Minoxidil users: time for application, amount used, frequency, spray vs dropper, etc. https://t.co/fFpYT6srKT
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment https://t.co/9MYmlWjm8Q a través de @JAMADerm part of @JAMANetwork
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment https://t.co/mdqvG3C3f8 via @JAMADerm part of @JAMANetwork
https://t.co/EpZgPB0Omb Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients A Network Meta-analysis デュタステリド5mgと書いてあってビックリした https://t.co/YDfap7LEfm
INPLASY202150083 - Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients A Network Meta-analysis https://t.co/qJ3SHfu8yY
Monotherapy with minoxidil, dutasteride and finasteride is used to manage androgenetic alopecia (AGA). The findings of this meta-analysis contribute to the comparative effectiveness literature for AGA therapies wrt the compared interventions. https://t.co/JoDPUkd24t